India and Israel are working together to develop a special type of rapid testing kit. If the experiment is successful, the test report of the corona will be available only within 30 seconds. Trial has started at Dr. Ram Manohar Lohia (RML) Hospital in Delhi 3 days ago. The results are expected in the next 2 weeks.Israel’s Directorate of Defense Research and Development (DRDD), India’s Defense Research and Development Organization (DRDO) are working together in this trial under the Ministry of External Affairs of India and Israel. It also includes the Council of Science and Industrial Research (CSIR).
The team of scientists arrived here 3 days ago on a special flight from Israel.
India helped Israel in every possible way
Israeli Ambassador Ron Malka said that the Prime Ministers of the two countries spoke during Corona. The two agreed to work together to find a solution to Corona. He said that if the research is successful, it will get results in a few seconds. Malka said that India helped Israel in every possible way during Corona. India also supplied the necessary raw materials for medicine and medicines to Israel. It is a sign of good friend.PMO’s Principal Scientific Advisor K.K. Vijay Raghavan said that India and Israel are partners in every field. The trust and relations that have been built between the two countries over the years will help in furthering this research.
I hope that we will be successful in this trial and it will be beneficial for our country and people.
Trial on 4 types of tests,4 different types of easy and non-invasive technology are being used in the trial. In this, a change in the voice of the patient is seen with the help of voice test, ie Artificial Intelligence. Breath analyzer, that is, the patient is asked to blow in a tube, to know the capacity of its langs. Also the test is done with Terra Wave. This shows the presence of virus.Isothermal testing is done to identify the virus in the patient’s saliva. Polyamino acids are used. This leads to the separation of Kovid-19 related proteins.